Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhongchao (ZCMD) Accumulated Expenses (2018 - 2025)

Zhongchao (ZCMD) reported Accumulated Expenses of $209191.0 for Q4 2025, up 4.9% year-over-year from $199418.0 in Q4 2024, and up 4.9% on a QoQ basis from $199418.0 in Q4 2024.

Zhongchao (ZCMD) has 8 years of Accumulated Expenses data on file, last reported at $209191.0 in Q4 2025.

  • Quarterly Accumulated Expenses rose 4.9% year-over-year to $209191.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $209191.0 (up 4.9% YoY) and the FY2025 annual result came in at $209191.0, up 4.9% from the prior year.
  • Accumulated Expenses grew to $209191.0 in Q4 2025 per ZCMD's latest filing, from $199418.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $974801.0 in Q4 2021 and bottomed at $199418.0 in Q4 2024.
  • The 5-year median for Accumulated Expenses is $296866.0 (2022), against an average of $416655.4.
  • The widest annual swing landed in 2022, when Accumulated Expenses sank 69.55%; it then surged 35.75% in 2023.
  • Tracing ZCMD's Accumulated Expenses over 5 years: stood at $974801.0 in 2021, then slumped by 69.55% to $296866.0 in 2022, then surged by 35.75% to $403001.0 in 2023, then sank by 50.52% to $199418.0 in 2024, then climbed by 4.9% to $209191.0 in 2025.
  • Per Business Quant, the three latest ZCMD Accumulated Expenses figures stand at $209191.0 (Q4 2025), $199418.0 (Q4 2024), and $403001.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Zhongchao - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 209,191.00
Dec 31, 2024 199,418.00
Dec 31, 2023 403,001.00
Dec 31, 2022 296,866.00
Dec 31, 2021 974,801.00
Dec 31, 2020 981,433.00
Dec 31, 2019 735,334.00
Dec 31, 2018 333,901.00